Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

A change in meningococcal serogroups in the west of Ireland?

Summary

Admission of patients to University College Hospital, Galway over a five month period commencing December 1989 indicates an increase in the incidence of Neisseria Meningitidis Serogroup C. Seven cases of Group C N. Meningitidishave been identified, five of them occurring over a four week period. A review of Meningococcal isolates occurring at this hospital over eleven years since 1979 shows, serogroup B as the predominant serogroup. Thirty-six isolates identified by serogrouping shows the distribution of serogroups as follows: Serogroup B 69.4%, Serogroup C 19.4%, Serogroup A 8.3%, Serogroup Z 2.7%.

Serogrouping, and when available, further serotyping of meningococcal isolates is very important in order to follow epidemiological trends in the disease and to monitor the serogroups that cause outbreaks. This information can influence measures that can be taken in the prevention of spread of the disease as for example the use of vaccination as appropriate.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Tauber, M. G. Saude, M. A., Landmark perspective: The impact of penicillin on the treatment of meningitis. J. Amer. Med. Assoc. 1984: 251, 1877–1880.

  2. 2.

    Frasch, C. E., Zollinger, W. D., Poolman, J. T. Serotype antigens of Neisseria Meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 1985: 7, 504–510.

  3. 3.

    Peltola, H. Meningococcal disease; still with us. Rev. Infct. Dis. 1983: 5, 71–91.

  4. 4.

    Lapeyssonie, L. La meningite cerebrospinal en Afrique. Bull. WHO 1963: 28 Suppl. 3–114.

  5. 5.

    Poolman, J. T., Lind, I., Jonsdottir, Froholm, L. O., Jones, D. M., Zanen, H. C. Meningococcal serotypes and serogroup B disease in North-West Europe. Lancet 1986: ii, 555–558.

  6. 6.

    PHLS Meningococcal Infections Working Party. CDR 89/08 February 24th 1989.

  7. 7.

    Fallon, R. J. Meningococcal infections in Scotland. Review. J. Med. Microbiol. 1988: 26, 161–187.

  8. 8.

    Calain, P., Poolman, J., Zollinger, W., Sperber, G., Bitter-Suermann, D., Auckenthaler, R., Hirschel, B. Serological study of Meningococcal Isolates in Switzerland and France 1980–1986. Eur. J. Clin. Microbiol. 1988:7, 788–791.

  9. 9.

    Stroffolini, T., Congii, M. E., Occhionero, M., Mastrantonio, P. Meningococcal disease in Italy. J. Infect. 1989: 19, 69–74.

  10. 10.

    Ronne, T., Iind, I., Buhl, L. H., Poolman, J. T., Zoffman, H. Recurrent localized outbreaks of Group C meningococcal disease and selective vaccination programmes. Antoine van Leeuwenhoek 1986: 52, 221–222.

  11. 11.

    Wright, J. Meningitis without pleocytosis. Pediatr. Infect. Dis. 1989: 8, 22.

  12. 12.

    Noah, N. D. Epidemiology of bacterial meningitis-UK and USA. In Williams, J. D., Bumie, J., eds. Bacterial Meningitis. London; Academic Press 1987.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Corbett-Feeney, G. A change in meningococcal serogroups in the west of Ireland?. I.J.M.S. 160, 134 (1991). https://doi.org/10.1007/BF02965936

Download citation

Keywords

  • Meningitis
  • Bacterial Meningitis
  • Sulphonamide
  • Meningococcal Disease
  • Neisseria Meningitidis